| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1666044A1 Male contraceptive formulation comprising norethisterone |
| 06/07/2006 | EP1666034A1 Pharmaceutical combination comprising a biguanide |
| 06/07/2006 | EP1666033A1 Prevention and treatment of androgen-deprivation induced osteoporosis |
| 06/07/2006 | EP1666031A1 Composition containing nanoparticles containing water-soluble basic drug encapsulated therein |
| 06/07/2006 | EP1666028A1 Dry powder compositions having improved dispersivity |
| 06/07/2006 | EP1666026A2 Non-aqueous single phase biocompatible viscous vehicles and methods for preparing the same |
| 06/07/2006 | EP1664008A1 Process for the preparation of amorphous form of repaglinide |
| 06/07/2006 | EP1663936A1 Biaryloxymethylarene-carboxylic acids |
| 06/07/2006 | EP1663296A1 Liquid human growth hormone formulation containing polyethylene glycol |
| 06/07/2006 | EP1663182A1 Rapid dissolution formulation of a calcium receptor-active compound |
| 06/07/2006 | EP1663161A2 Slow release estradiol-progesterone formulation for contraception and hormone replacement therapy |
| 06/07/2006 | EP1567516B1 Method for the purification of liponic acid |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1334367B1 A method of determining the initial dose of vitamin d compounds |
| 06/07/2006 | EP1124592B1 Textured and porous silicone rubber |
| 06/07/2006 | CN1784379A Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 06/07/2006 | CN1781935A Novel LHRH antagonist |
| 06/07/2006 | CN1781536A Chinese medicine compound preparation for treating hyperthyoidism |
| 06/07/2006 | CN1781487A OCT preparations |
| 06/07/2006 | CN1258563C Highly-neutralized ethylene copolymers and their use in golf balls |
| 06/06/2006 | US7057076 which have improved receptor binding affinity via substituted alkyl side chains at the c-3 position; may contain terpene funtionality combined with resorcinol moieties; for treatment of nervous system disorders and cardiovascular disorders |
| 06/06/2006 | US7056944 Pyrazole compositions useful as inhibitors of erk |
| 06/06/2006 | US7056933 For therapy of arthritis, fever, common cold, dysmenorrhea, menstrual cramps, inflammatory bowel disease, Crohn's disease, emphysema, acute respiratory distress syndrome, asthma, bronchitis, chronic obstructive pulmonary disease, etc. |
| 06/06/2006 | US7056931 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| 06/06/2006 | US7056927 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 06/06/2006 | US7056904 Therapy for bone disorders; osteoporosis; vitamin deficiency |
| 06/06/2006 | US7056512 controlling and increasing muscle growth, especially in farm animals for slaughter, by administering an immunogenically effective amount ofa modified GDF-8 polypeptide |
| 06/06/2006 | CA2242577C Skin-adhering pharmaceutical preparation, in particular transdermal therapeutic system for the release of 17-.beta.-estradiol to the human organism |
| 06/06/2006 | CA2158973C 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 06/01/2006 | WO2006057270A1 Nitrogeneous tricyclic compound |
| 06/01/2006 | WO2006057152A1 Therapeutic agent for diabetes comprising protease-inhibiting compound |
| 06/01/2006 | WO2003025542A3 Immune response associated proteins |
| 06/01/2006 | US20060116516 2-[[4-[[[4-(Aminosulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-4-methyl-5-thiazolecarboxylic acid, ethyl ester; 4-Methyl-2-[[4-[[[4-(methylsulfonyl)phenyl]methyl]amino]pyrido[2,3-d]pyrimidin-2-yl]amino]-5-thiazolecarboxylic acid, ethyl ester; Antiinflammatory agents; rheumatic diseases |
| 06/01/2006 | US20060116510 Isoflavone concentrates, as well as methods for their production |
| 06/01/2006 | US20060116385 Novel compounds having selective inhibiting effect at gsk3 |
| 06/01/2006 | US20060116381 4-4(methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-ben-zamide for treating mutated-ret kinase associated diseases |
| 06/01/2006 | US20060116362 Nobel compounds having selective inhibiting effect at gsk3 |
| 05/31/2006 | EP1661898A1 Bicyclic piperazine compound and use thereof |
| 05/31/2006 | EP1661889A1 Chemokine receptor antagonist and medical use thereof |
| 05/31/2006 | EP1660531A2 Novel insulin derivatives |
| 05/31/2006 | EP1660184A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 05/31/2006 | EP1660091A1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 05/31/2006 | EP1660009A2 Methods for the treatment of endometriosis |
| 05/31/2006 | EP1659918A2 Antibodies directed to parathyroid hormone (pth) and uses thereof |
| 05/31/2006 | EP1419178B1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/31/2006 | EP1352061B1 Method for inhibiting the expression of a target gene |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1263467B1 Paste formulations comprising silica |
| 05/31/2006 | EP1242012A4 Improved transdermal contraceptive delivery system and process |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | CN1257916C Parathyroid hormone analog and its preparing process by recombination |
| 05/31/2006 | CN1257913C 17alpha-hydroxy-14beta-steroids with hormonal effect |
| 05/30/2006 | US7053228 Cushing disease; antidepressant; modulate immunology response |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053091 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |
| 05/30/2006 | US7053083 Medicine for inducing temporary delay of urination or treatment of disorders of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or bleeding and coagulation disorders |
| 05/30/2006 | US7053077 such as estrone sulfamate and/or estradiol sulfamate for oral administration or for use in intrauterine releasing system (IUD) |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7053054 Purified LH |
| 05/30/2006 | US7053045 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 05/30/2006 | US7052717 Storage stable thyroxine active drug formulations and methods for their production |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/26/2006 | WO2006055694A1 Novel 2h-chromene derivatives as selective estrogen receptor modulators |
| 05/26/2006 | WO2006055659A2 Fixed dose combination op dutasteride and tamsulosin |
| 05/26/2006 | WO2006054641A1 Gpr7-selective ligand and use thereof |
| 05/26/2006 | WO2006031786A3 Protein a compositions and methods of use |
| 05/26/2006 | WO2006027052A3 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 05/26/2006 | WO2006021007A3 Effervescent composition including alternative hormone replacement therapy agent |
| 05/26/2006 | WO2006006079A3 Methods for suppressing neovascularization using ephrinb2 |
| 05/26/2006 | WO2005020880A3 Methods for the treatment of endometriosis |
| 05/26/2006 | CA2587669A1 Novel 2h-chromene derivatives as selective estrogen receptor modulators |
| 05/26/2006 | CA2587398A1 Gpr7-selective ligand and use thereof |
| 05/25/2006 | US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
| 05/25/2006 | US20060111408 Therapeutic benzothiazole compounds |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111362 1,3-Dihydroimidazole ring compound |
| 05/24/2006 | EP1659176A1 Oligonucleotide inhibiting the expression of star-binding protein (sbp) gene and method therefor |
| 05/24/2006 | EP1658856A1 Exendins for glucagon suppression |
| 05/24/2006 | EP1658849A2 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 05/24/2006 | EP1658306A1 Delta 15 -d-homosteroids having an androgenic effect |
| 05/24/2006 | EP1658087A1 Blood sugar regulating agent comprising a natural dry product derived from from soya bean seeds alone or in a mixture and preparation thereof |
| 05/24/2006 | EP1478613B1 Substituted 10-aryl-11h-benzo¬b|fluorenes for selective effects on estrogen receptors |
| 05/24/2006 | EP1334106B1 Imidazole derivatives, production method thereof and use thereof |
| 05/24/2006 | EP1333841B1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/24/2006 | EP1259520B1 Novel purines |
| 05/24/2006 | EP1100492B1 INDOLE sPLA2 INHIBITORS |
| 05/24/2006 | EP0858337B1 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/24/2006 | CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 05/24/2006 | CN1775271A Hyperfunction-inhibiting preparation and new preparing method |
| 05/24/2006 | CN1257181C Androfenic Steroid compounds and method of making and using the same |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity |
| 05/23/2006 | US7049286 Insulin conjugates and methods of use thereof |
| 05/23/2006 | US7048914 Placental alkaline phosphatase to control diabetes |
| 05/18/2006 | WO2006051987A1 Novel drug for inhibiting estrogen-dependent diseases, prostaglandin d (pgd)-dependent gynecological diseases, immunological diseases, cancer and angiogenesis |